Maven Securities LTD Chinook Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $1.61 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$12.02 - $16.69 $339,793 - $471,809
-28,269 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$10.69 - $16.83 $302,195 - $475,767
28,269 New
28,269 $461,000
Q3 2021

Nov 15, 2021
SELL
$11.5 - $14.86 $399,935 - $516,786
-34,777 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.6 - $18.98 $472,967 - $660,067
34,777 New
34,777 $494,000

Others Institutions Holding KDNY

# of Institutions
4
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email